Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Lithium carbonate
Drug ID BADD_D01303
Description Lithium has been used to treat manic episodes since the 19th century[A176642]. Though it is widely used, its mechanism of action is still unknown[FDA Label][A14585,A176642,A176651,L5843]. Lithium carbonate has a narrow therapeutic range and so careful monitoring is required to avoid adverse effects[FDA Label].
Indications and Usage Lithium is used as a mood stabilizer, and is indicated for the treatment of manic episodes and maintenance of bipolar disorder[FDA Label].
Marketing Status approved
ATC Code Not Available
DrugBank ID DB14509
KEGG ID D00801
MeSH ID D016651
PubChem ID 11125
TTD Drug ID D04UUH
NDC Product Code 31722-546; 62332-148; 62756-430; 63187-304; 64980-205; 68462-221; 70518-0608; 70518-2312; 70518-2345; 70518-3565; 72789-171; 72789-172; 31722-544; 62332-014; 68071-2714; 0054-8531; 46708-303; 55154-4920; 63629-1916; 0378-1450; 70518-0668; 70518-3681; 0054-4527; 62332-013; 68462-220; 68462-222; 68462-223; 70518-0437; 70518-2699; 68084-655; 70518-1434; 0054-2531; 71335-0120; 0054-8528; 0615-8302; 50090-3917; 58118-0545; 0054-8526; 51079-142; 63629-1917; 68462-224; 71610-557; 72789-173; 39345-5104; 46708-305; 0378-1300; 64980-278; 70518-1753; 70518-2086; 0054-2526; 31722-545; 50090-1470; 62332-015; 62559-280; 0054-0020; 68428-481; 0054-2527; 72789-174; 82388-001; 46708-148; 50090-6052; 64117-256; 0054-0021; 68084-640; 70518-0904; 70518-1481; 0054-8527; 66039-947; 73309-248; 23155-763; 42291-496; 43063-901; 46708-304; 51079-180
UNII 2BMD2GNA4V
Synonyms Lithium Carbonate | Carbonate, Lithium | Dilithium Carbonate | Carbonate, Dilithium | Lithane | Lithium Bicarbonate | Bicarbonate, Lithium | Lithobid | Lithonate | CP-15,467-61 | CP 15,467 61 | CP15,46761 | Micalith | NSC-16895 | NSC 16895 | NSC16895 | Priadel | Quilinorm-retard | Quilinorm retard | Quilinormretard | Eskalith | Lithotabs
Chemical Information
Molecular Formula CLi2O3
CAS Registry Number 554-13-2
SMILES [Li+].[Li+].C(=O)([O-])[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.0020.002142%Not Available
Breast engorgement21.05.05.002; 18.08.02.0010.000535%Not Available
Bundle branch block left02.03.01.0070.001071%Not Available
Bundle branch block right02.03.01.0110.000803%Not Available
Cardiac arrest02.03.04.0010.002142%
Cardiac failure acute02.05.01.0050.000535%Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.001071%Not Available
Cardiogenic shock02.05.01.003; 24.06.02.0060.000535%Not Available
Cataract06.06.01.001--
Catatonia19.11.01.0010.001071%Not Available
Cerebellar atrophy17.11.01.0080.000535%Not Available
Cerebellar syndrome17.02.02.0020.001071%Not Available
Cerebral atrophy17.11.01.0010.000535%Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.009--Not Available
Chest pain22.12.02.003; 02.02.02.011; 08.01.08.0020.001606%Not Available
Choking22.12.03.0030.000535%Not Available
Choreoathetosis17.01.01.0030.000803%Not Available
Clonus17.02.05.0020.000535%Not Available
Cogwheel rigidity17.01.05.001; 15.05.04.006--Not Available
Coma17.02.09.0010.001606%Not Available
Completed suicide19.12.01.001; 08.04.01.0100.002409%Not Available
Condition aggravated08.01.03.0040.001874%Not Available
Confusional state19.13.01.001; 17.02.03.0050.006157%
Constipation07.02.02.0010.001606%
Coordination abnormal17.02.02.004--Not Available
Coronary artery disease24.04.04.006; 02.02.01.0010.000535%Not Available
Creatinine renal clearance decreased13.13.01.013--Not Available
Crying08.01.03.005; 19.04.02.002; 17.02.05.013; 12.02.11.0010.000803%Not Available
Dehydration14.05.05.0010.004015%
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 11 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene